Breadcrumb

Platform News

RI-MUHC and McGill awarded $5.1 million for infectious disease research

A new grant from the Canada Foundation for Innovation will invest in leading edge Containment Level 3...

Instrument Demo – Zeiss Axio Observer 7

Hosted by the Molecular Imaging Platform in collaboration with Zeiss Canada

RI-MUHC trainee Prisca Bustamante honoured by Mitacs Award for Outstanding Innovation

Doctoral student develops world's first non-invasive blood screening test for uveal melanoma

RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response

Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...

Platform Expo 2021

The RI-MUHC Technology Platforms invite you to attend the Platform Expo Webinar on October 7, 2021.

New G protein inhibitor identified, with potential for cancer therapies

RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells

RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer

Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...

How does the hunger-suppressing hormone leptin cross the blood-brain barrier?

Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC

Learn more about the RI-MUHC